Navigation Links
Genedata Expressionist® 13.0 Streamlines In-depth Characterization and Automates Quality Monitoring of Biopharmaceuticals
Date:6/3/2019

Genedata, a leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the release of Genedata Expressionist 13.0 at the 2019 ASMS Conference. The release streamlines mass spectrometry (MS)-based characterization of biotherapeutics and automates knowledge-assisted analysis, with a special focus on implementing Multi-Attribute Methods (MAM) to monitor the quality of biopharmaceuticals throughout biopharmaceutical development and manufacturing.

Developed in close collaboration with partners across the biopharmaceutical industry, Genedata Expressionist provides unique workflow solutions addressing specific customer needs through out-of-the-box software functionalities. These solutions can be configured to automate complex MS data processing steps, enabling customers to scale up their experimental throughput.

The new release includes the following highlights:

  • A new, flexible, user-definable approach to peptide mapping and sequence variant analysis (SVA) that reduces false-positive annotations while maximizing sensitivity, enabling best-in-class molecule characterization—important for next-generation Multi-Attribute Method (MAM) implementations.
  • Advanced iterative review and commenting capabilities together with insightful visualizers that streamline the curation of peptide mapping results. Further, curated results can now be easily incorporated as custom libraries and leveraged in downstream MAM monitoring processes, aiding automated quantification of Critical Quality Attributes (CQAs).
  • Increased configurability allowing customized reporting and preventing time-consuming report reformatting. A unique integrated report approval process with signing functionalities makes Genedata Expressionist the solution-of-choice for MAM deployment in regulated environments.

Beyond streamlining workflows for characterization of biopharmaceuticals, Genedata Expressionist is increasingly being adopted to automate Host-Cell Protein (HCP) analysis due to its advanced built-in capabilities for proteomics analysis. As an instrument- and vendor-agnostic software platform, Genedata Expressionist continues to support the latest high-end MS instruments and thereby create new analytical solutions that address unmet needs. For this release, Genedata worked closely with Bruker to support their novel timsTOF Pro instrument; providing customers with a high-performance HCP and proteomics analytical system that offers unparalleled speed, scalability, and sensitivity.

By streamlining and automating complex MS data processing, analysis, and reporting workflows within and across laboratories, Genedata Expressionist empowers scientists to make informed decisions based on high-quality results.

“The latest release of Genedata Expressionist—an important component of our Genedata Biopharma Platform— reinforces our continued commitment to support the rapidly evolving needs of the biopharmaceutical industry, such as support of MAM. Genedata Expressionist enables our customers to efficiently scale up their internal data processing workflows, while at the same time improving result quality.” commented Dr. Othmar Pfannes, CEO of Genedata. “Furthermore, we remain committed to partnering with leading technology providers such as Bruker to offer our joint customers new solutions to not only accelerate discovery, development, and commercialization of novel biopharmaceuticals, but ultimately also to reduce costs by streamlining and automating complex analytical processes.”

Read the full story at https://www.prweb.com/releases/genedata_expressionist_13_0_streamlines_in_depth_characterization_and_automates_quality_monitoring_of_biopharmaceuticals/prweb16352881.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Takara Bio Selects Genedata Software to Automate and Standardize NGS Data Analysis
2. Frost & Sullivan Honors Clinical Ink for Developing an eSource Platform that Streamlines Clinical Development
3. Hospital Streamlines ICU Efficiency with Timely Data Integration
4. QIAGENs GeneReader NGS System Streamlines Data Management for Labs
5. Pharmaceutical Market Deal Trends (2010-2015): In-Depth Analysis of Recent Deal Activity in New Research Report
6. Mauna Kea Technologies Announces Publication of Confirmation Data on the Value of Endomicroscopy for the Characterization of Pancreatic Cystic Neoplasms
7. New Publication Confirms Important Role of Needle-Based Endomicroscopy for the Characterization of Pancreatic Cysts
8. Innovative Cell-Isolation System Points to New Model of Clinical Biopsy for Precise Characterization, Diagnosis and Treatment of Tumors
9. Mauna Kea Technologies Completes Enrollment of 200 Patient Contact II Study on Characterization of Pancreatic Cysts with Needle-Based Confocal Laser Endomicroscopy
10. New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines
11. For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2019)... ... December 06, 2019 , ... ... of treatments for psychiatric and neurodegenerative disorders, announced today that the U.S. Food ... NBTX-001 Inhaler, allowing the Company to initiate its Phase 2b trial for the ...
(Date:12/5/2019)... ... December 05, 2019 , ... ... entrance into the Amazon Web Services (AWS) Public Sector Partner Program; a ... Public Sector Partner program recognizes and collaborates with partners that offer solutions ...
(Date:12/4/2019)... ... December 04, 2019 , ... Tenex ... minimally invasive technologies to treat chronic pain in soft and hard tissue, recently ... TX® technology. , Dr. Bernard Morrey, Chief Medical Officer of Tenex ...
Breaking Medicine Technology:
(Date:12/6/2019)... ... December 06, 2019 , ... Allegheny Health Network (AHN) has named ... joined AHN from WVU Medicine in May 2018, previously served as AHN’s Vice Chair ... interim chair since October and is also part of the pathology faculty at Drexel ...
(Date:12/6/2019)... ... December 06, 2019 , ... Dr. Scott Howell, a 2019 graduate of Trident ... the health benefits of coconut oil in the 7 November 2019 edition of ... Cardiometabolic Profile: A Structured Literature Review,” led by Dr. Hector O. Santos, examines the ...
(Date:12/5/2019)... ... December 05, 2019 , ... ... ranging from launching exceptional products that help people embrace, achieve, and maintain a ... “We’ve never been more committed to our mission of impacting world health, so ...
(Date:12/4/2019)... ... December 04, 2019 , ... Healthcare Real ... the only national awards dedicated to recognizing excellence in the areas of healthcare ... presented in nine different categories during the GlobeSt Healthcare Conference today in Scottsdale, ...
(Date:12/2/2019)... ... December 02, 2019 , ... TrialScope, the global leader ... the North American branch of the healthcare business of Merck KGaA, Darmstadt, Germany, ... educate and inform patients, caregivers, the public, patient advocacy groups and healthcare professionals ...
Breaking Medicine News(10 mins):